NEW YORK (GenomeWeb) – Synthetic biology firm Synthorx launched today with exclusive rights to a technology developed by a researcher at the Scripps Research Institute.

Based in San Diego, Synthorx also has received an investment from Avalon Ventures and Correlation Ventures, though it didn't disclose the amount of the funding.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.